Munich-based HealthTech startup Vantis has taken a major step forward, successfully closing a €10 million Series A funding round to transform primary healthcare. As reported by StartingUp. the company combines digital technology and traditional care to rethink treatment for chronic patients — and investors clearly believe in the mission.
The round was led by Angelini Ventures, the investment arm of Angelini Industries, with participation from Bayern Kapital, Twip Impact Ventures, and existing investors firstminute and b2venture. The funds will support Vantis’s approach to managing chronic conditions with data, and the expansion of telemedicine, continuous monitoring, digital therapies, and AI-supported processes. “As a company that operates its own practices, we can tailor technology to the real-world challenges of primary care,” said co-founder and CEO Till Jansen.
Vantis focuses on chronically ill patients, offering full-service primary care through its own clinics and digital solutions. The results are already promising: by streamlining processes and leveraging technology, Vantis increases the number of patients each doctor can serve — critical amid Germany’s healthcare workforce shortage. In rural areas, the lack of physicians is especially acute, while the number of chronic patients is rising. Vantis addresses this with telehealth and remote monitoring, allowing doctors to work more efficiently and patients to receive quality care.
The company’s ambitions are high: Vantis plans to significantly expand its Munich team, especially in tech, operations, and management, and to scale its outpatient clinic network. “We want to build modern, digital structures that ease the burden on doctors and improve treatment outcomes,” Jansen added. Investors share this vision: Nils Bottler of Angelini Ventures called Vantis’s model a “rethink of primary care” with the potential to solve healthcare challenges across Europe.
Amid growing interest in HealthTech — investment in the sector in Europe rose by 12% in 2024 — Vantis’s success looks promising. But can the startup manage the challenges of scaling and competition in a hot market? For now, Vantis is proving that technology can make healthcare more accessible and effective.
